Xi'an Libang Pharmaceutical Co.,ltd.

Overview

Xi'an Libang Pharmaceutical Co.,ltd. is a pharmaceutical company headquartered in Xi'an, China.

Active ingredients with DMF or CEP filings

Substances for which Xi'an Libang Pharmaceutical Co.,ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Xi'an Libang Pharmaceutical Co.,ltd. holds 0 active (7 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • MELPHALAN HYDROCHLORIDE (NON STERILE BULK DRUG SUBSTANCE)Inactive2010-04-01
  • SUCCINYLCHOLINE CHLORIDEInactive2009-05-15
  • IBUTILIDE FUMARATE, NON-STERILE BULK DRUGInactive2008-04-14
  • DIATRIZOIC ACID BULKInactive2005-04-15
  • AMLODIPINE MALEATE AND BESYLATE (NON-STERILE BULK DRUG SUBSTANCE)Inactive2004-01-23
  • METOLAZONE USPInactive2002-06-10
  • DROPERIDOL USP, NON-STERILE BULK DRUG INTENDED FOR HUMAN USEInactive1998-12-16

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Xi'an Libang Pharmaceutical Co.,ltd. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Xi'an Libang Pharmaceutical Co.,ltd.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.